Paper Chase is a research database designed to offer abstracts of research articles published in journals that have a highly rated impact factor as determined by ISI Impact Factor and PageRank. Abstracts are organized by date, with the most recently published papers listed first. 

Paper Chase

141.

Challenges in clinical trial design for HIV-1 cure research.

Lancet.
Eyal N, Kuritzkes DR.
| Nov 2, 2013
142.

Male hypogonadism.

Lancet.
Basaria S.
| Apr 5, 2014
143.

Ramucirumab monotherapy for previously treated advanced gastric or gastro-oesophageal junction adenocarcinoma (REGARD): an international, randomised, multicentre, placebo-controlled, phase 3 trial.

Lancet.
Fuchs CS, Tomasek J, Yong CJ, Dumitru F, Passalacqua R, Goswami C, Safran H, dos Santos LV, Aprile G, Ferry DR, Melichar B, Tehfe M, Topuzov E, Zalcberg JR, Chau I, Campbell W, Sivanandan C, Pikiel J, Koshiji M, Hsu Y, Liepa AM, Gao L, Schwartz JD, Tabernero J, Mendez G.
| Jan 4, 2014
144.

The Framingham Heart Study and the epidemiology of cardiovascular disease: a historical perspective.

Lancet.
Mahmood SS, Levy D, Vasan RS, Wang TJ.
| Mar 15, 2014
145.

Effect of cangrelor on periprocedural outcomes in percutaneous coronary interventions: a pooled analysis of patient-level data.

Lancet.
Steg PG, Bhatt DL, Hamm CW, Stone GW, Gibson CM, Mahaffey KW, Leonardi S, Liu T, Skerjanec S, Day JR, Iwaoka RS, Stuckey TD, Gogia HS, Gruberg L, French WJ, White HD, Harrington RA.
| Dec 14, 2013
146.

Intracranial atherosclerosis.

Lancet.
Qureshi AI, Caplan LR.
| Mar 15, 2014
147.

Delirium in elderly people.

Lancet.
Inouye SK, Westendorp RG, Saczynski JS.
| Mar 8, 2014
148.

Prasugrel versus clopidogrel for patients with unstable angina or non-ST-segment elevation myocardial infarction with or without angiography: a secondary, prespecified analysis of the TRILOGY ACS trial.

Lancet.
Wiviott SD, White HD, Ohman EM, Fox KA, Armstrong PW, Prabhakaran D, Hafley G, Lokhnygina Y, Boden WE, Hamm C, Clemmensen P, Nicolau JC, Menozzi A, Ruzyllo W, Widimsky P, Oto A, Leiva-Pons J, Pavlides G, Winters KJ, Roe MT, Bhatt DL.
| Aug 17, 2013
149.

Adult obstructive sleep apnoea.

Lancet.
Jordan AS, McSharry DG, Malhotra A.
| Feb 22, 2014
150.

WHO's new HIV guidelines: opportunities and challenges.

Lancet.
Mayer K, Beyrer C.
| Jul 27, 2013
151.

Karyomegalic interstitial nephritis.

Lancet.
Zschiedrich S, Huber TB, Hildebrandt F, Mihatsch MJ, Wiech T.
| Dec 21, 2013
152.

Teriparatide and denosumab, alone or combined, in women with postmenopausal osteoporosis: the DATA study randomised trial.

Lancet.
Tsai JN, Uihlein AV, Lee H, Kumbhani R, Siwila-Sackman E, McKay EA, Burnett-Bowie SA, Neer RM, Leder BZ.
| Jul 6, 2013
153.

First-line treatment of indolent lymphoma: axing CHOP?

Lancet.
Jacobson CA, Freedman AS.
| Apr 6, 2013
154.

Metchnikoff and the microbiome.

Lancet.
Podolsky SH.
| Nov 24, 2012
155.

Efficacy and safety of regorafenib for advanced gastrointestinal stromal tumours after failure of imatinib and sunitinib (GRID): an international, multicentre, randomised, placebo-controlled, phase 3 trial.

Lancet.
Demetri GD, Reichardt P, Kang YK, Blay JY, Rutkowski P, Gelderblom H, Hohenberger P, Leahy M, von Mehren M, Joensuu H, Badalamenti G, Blackstein M, Le Cesne A, Schöffski P, Maki RG, Bauer S, Nguyen BB, Xu J, Nishida T, Chung J, Kappeler C, Kuss I, Laurent D, Casali PG, Samonigg H.
| Jan 26, 2013
156.

Efficacy, safety, and tolerability of a monoclonal antibody to proprotein convertase subtilisin/kexin type 9 in combination with a statin in patients with hypercholesterolaemia (LAPLACE-TIMI 57): a randomised, placebo-controlled, dose-ranging, phase 2 study.

Lancet.
Giugliano RP, Desai NR, Kohli P, Rogers WJ, Somaratne R, Huang F, Liu T, Mohanavelu S, Hoffman EB, McDonald ST, Abrahamsen TE, Wasserman SM, Scott R, Sabatine MS.
| Dec 8, 2012
157.

Ventricular arrhythmias and sudden cardiac death.

Lancet.
John RM, Tedrow UB, Koplan BA, Albert CM, Epstein LM, Sweeney MO, Miller AL, Michaud GF, Stevenson WG.
| Oct 27, 2012
158.

Postoperative radiation for prostate cancer.

Lancet.
Efstathiou JA.
| Dec 8, 2012
159.

Health-care reforms in the USA and England: areas for useful learning.

Lancet.
Blumenthal D, Dixon J.
| Oct 13, 2012
160.

EXAMINATION of new drug-eluting stents--top of the class!

Lancet.
Bhatt DL.
| Oct 27, 2012